2002, Value inquiry book series, ISBN 9789042014404, Volume 130, xiii, 135
Book
Book
JAMA Psychiatry, ISSN 2168-622X, 02/2015, Volume 72, Issue 2, pp. 143 - 151
IMPORTANCE: People with severe mental illness (SMI), including schizophrenia and bipolar disorder, have excess rates of cardiovascular disease (CVD). Risk...
MORTALITY | METABOLIC SYNDROME | PRIMARY-CARE | EVENTS | PSYCHIATRY | SCHIZOPHRENIA | RELATIVE RISK | Prognosis | Comorbidity | Humans | Middle Aged | Male | Risk | Models, Statistical | Psychotic Disorders - epidemiology | Schizophrenia - epidemiology | Electronic Health Records - statistics & numerical data | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Female | Aged | United Kingdom - epidemiology | Bipolar Disorder - epidemiology | Cardiovascular Diseases - diagnosis | Complications and side effects | Cardiovascular diseases | Mental illness | Health aspects | Risk factors | Mentally ill
MORTALITY | METABOLIC SYNDROME | PRIMARY-CARE | EVENTS | PSYCHIATRY | SCHIZOPHRENIA | RELATIVE RISK | Prognosis | Comorbidity | Humans | Middle Aged | Male | Risk | Models, Statistical | Psychotic Disorders - epidemiology | Schizophrenia - epidemiology | Electronic Health Records - statistics & numerical data | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Female | Aged | United Kingdom - epidemiology | Bipolar Disorder - epidemiology | Cardiovascular Diseases - diagnosis | Complications and side effects | Cardiovascular diseases | Mental illness | Health aspects | Risk factors | Mentally ill
Journal Article
Drugs, ISSN 0012-6667, 07/2015, Volume 75, Issue 11, pp. 1201 - 1201
Since their introduction, statin (HMG-CoA reductase inhibitor) drugs have advanced the practice of cardiology to unparalleled levels. In this review, the...
Journal Article
Drugs, ISSN 0012-6667, 07/2015, Volume 75, Issue 11, pp. 1187 - 1187
Coronary heart disease (CHD) is the leading cause of death in most countries, with the high prevalence currently driven by dual epidemics of obesity and...
Journal Article
Drugs, ISSN 0012-6667, 07/2015, Volume 75, Issue 11, pp. 1187 - 1199
Coronary heart disease (CHD) is the leading cause of death in most countries, with the high prevalence currently driven by dual epidemics of obesity and...
RECENT CLINICAL-TRIALS | LIFETIME RISK | METAANALYSIS | TASK-FORCE | CHOLESTEROL | INSULIN-RESISTANCE | LOW-DENSITY-LIPOPROTEIN | PHARMACOLOGY & PHARMACY | TOXICOLOGY | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK | PRIMARY PREVENTION | Coronary Disease - prevention & control | Dyslipidemias - drug therapy | Dyslipidemias - complications | United States | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Drug Design | Risk | Drug Approval | United States Food and Drug Administration | Practice Guidelines as Topic
RECENT CLINICAL-TRIALS | LIFETIME RISK | METAANALYSIS | TASK-FORCE | CHOLESTEROL | INSULIN-RESISTANCE | LOW-DENSITY-LIPOPROTEIN | PHARMACOLOGY & PHARMACY | TOXICOLOGY | CORONARY-HEART-DISEASE | CARDIOVASCULAR RISK | PRIMARY PREVENTION | Coronary Disease - prevention & control | Dyslipidemias - drug therapy | Dyslipidemias - complications | United States | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Drug Design | Risk | Drug Approval | United States Food and Drug Administration | Practice Guidelines as Topic
Journal Article
Drugs, ISSN 0012-6667, 07/2015, Volume 75, Issue 11, pp. 1201 - 1228
Since their introduction, statin (HMG-CoA reductase inhibitor) drugs have advanced the practice of cardiology to unparalleled levels. Even so, coronary heart...
C-REACTIVE PROTEIN | RESIDUAL CARDIOVASCULAR RISK | PROLIFERATOR-ACTIVATED RECEPTORS | HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | POLYUNSATURATED FATTY-ACIDS | TRIGLYCERIDE-RICH LIPOPROTEINS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | HIGH-DENSITY-LIPOPROTEIN | Coronary Disease - prevention & control | Dyslipidemias - drug therapy | Animals | Dyslipidemias - complications | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Drug Design | Coronary Disease - etiology | Drug Approval | Hypolipidemic Agents - therapeutic use | Hypolipidemic Agents - pharmacology
C-REACTIVE PROTEIN | RESIDUAL CARDIOVASCULAR RISK | PROLIFERATOR-ACTIVATED RECEPTORS | HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | POLYUNSATURATED FATTY-ACIDS | TRIGLYCERIDE-RICH LIPOPROTEINS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | HIGH-DENSITY-LIPOPROTEIN | Coronary Disease - prevention & control | Dyslipidemias - drug therapy | Animals | Dyslipidemias - complications | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Drug Design | Coronary Disease - etiology | Drug Approval | Hypolipidemic Agents - therapeutic use | Hypolipidemic Agents - pharmacology
Journal Article
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 105 - 106
[...]practical and foundational measures, such as improving medication adherence and addressing social determinants of health to further primary prevention,...
MEDICINE, GENERAL & INTERNAL | ADHERENCE | DISEASE | Cardiovascular System | Cardiovascular Diseases | Humans | Low income groups | Heart | Drugs | Physicians | Income | Cardiovascular disease | Social factors | Socioeconomics | Risk factors | Ultrasonic imaging | Risk assessment | Atherosclerosis | Heart diseases | Ultrasound | Medical personnel | Mortality | Socio-economic aspects | Health risks | Risk analysis | Patients | Adhesion | Coronary artery disease | Socioeconomic data | Arteriosclerosis | Cardiovascular diseases
MEDICINE, GENERAL & INTERNAL | ADHERENCE | DISEASE | Cardiovascular System | Cardiovascular Diseases | Humans | Low income groups | Heart | Drugs | Physicians | Income | Cardiovascular disease | Social factors | Socioeconomics | Risk factors | Ultrasonic imaging | Risk assessment | Atherosclerosis | Heart diseases | Ultrasound | Medical personnel | Mortality | Socio-economic aspects | Health risks | Risk analysis | Patients | Adhesion | Coronary artery disease | Socioeconomic data | Arteriosclerosis | Cardiovascular diseases
Journal Article
International Organisations Research Journal, ISSN 1996-7845, 2018, Volume 13, Issue 2, pp. 143 - 172
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 201 - 16
Inhibition of the PARP superfamily tankyrase enzymes suppresses Wnt/beta-catenin signalling in tumour cells. Here, we describe here a novel, drug-like small...
TARGET | AXIN | WNT/BETA-CATENIN | MULTIDISCIPLINARY SCIENCES | MUTATION | GROWTH | KINASE 4/6 | YAP | PROLIFERATION | LUNG-CANCER CELLS | WNT | Phenotypes | Senescence | Wnt protein | Stem cell transplantation | Poly(ADP-ribose) polymerase | siRNA | Drug resistance | Cyclin-dependent kinase 4 | Cyclin D2 | β-catenin | Intestine | Stem cells | Cell cycle | Tumors
TARGET | AXIN | WNT/BETA-CATENIN | MULTIDISCIPLINARY SCIENCES | MUTATION | GROWTH | KINASE 4/6 | YAP | PROLIFERATION | LUNG-CANCER CELLS | WNT | Phenotypes | Senescence | Wnt protein | Stem cell transplantation | Poly(ADP-ribose) polymerase | siRNA | Drug resistance | Cyclin-dependent kinase 4 | Cyclin D2 | β-catenin | Intestine | Stem cells | Cell cycle | Tumors
Journal Article
Annals of Medicine, ISSN 0785-3890, 04/2017, Volume 49, Issue 3, pp. 260 - 274
Despite striking extensions of lifespan, leading causes of death in most countries now constitute chronic, degenerative diseases which outpace the capacity of...
epidemiology | health disparities | health literacy | chronic disease | adherence | Cardiovascular disease | diabetes type 2 | dyslipidemia | prevention | obesity | RISK-FACTORS | MYOCARDIAL-INFARCTION | LONG-TERM SURVIVAL | MIDDLE-INCOME | AMERICAN-COLLEGE | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE | CARDIOVASCULAR-DISEASE | ASSOCIATION TASK-FORCE | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | Health Literacy - statistics & numerical data | United States - epidemiology | Prevalence | Age Factors | Communicable Diseases - epidemiology | Awareness | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Chronic Disease - epidemiology | Mortality - trends | Morbidity | Diabetes Mellitus, Type 2 - epidemiology | Patient Compliance - statistics & numerical data | Civilization | Life Expectancy | Obesity - epidemiology | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cause of Death - trends | Developing Countries | Global Health - standards | Communicable Diseases - mortality
epidemiology | health disparities | health literacy | chronic disease | adherence | Cardiovascular disease | diabetes type 2 | dyslipidemia | prevention | obesity | RISK-FACTORS | MYOCARDIAL-INFARCTION | LONG-TERM SURVIVAL | MIDDLE-INCOME | AMERICAN-COLLEGE | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE | CARDIOVASCULAR-DISEASE | ASSOCIATION TASK-FORCE | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | Health Literacy - statistics & numerical data | United States - epidemiology | Prevalence | Age Factors | Communicable Diseases - epidemiology | Awareness | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Chronic Disease - epidemiology | Mortality - trends | Morbidity | Diabetes Mellitus, Type 2 - epidemiology | Patient Compliance - statistics & numerical data | Civilization | Life Expectancy | Obesity - epidemiology | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cause of Death - trends | Developing Countries | Global Health - standards | Communicable Diseases - mortality
Journal Article
Medical Principles and Practice, ISSN 1011-7571, 02/2018, Volume 26, Issue 6, pp. 497 - 508
Amidst voluminous literature, inconsistencies and opposing results have confused rather than clarified cardiologists' ability to assess the potential benefits...
Review | Cardiovascular outcomes | Heart failure | Myocardial infarction | Atherosclerosis | Cardiovascular disease | Inflammation | Endothelial function | Coronary heart disease | Arrhythmias | N-3 polyunsaturated fatty acids | CHRONIC HEART-FAILURE | LONG-CHAIN OMEGA-3-FATTY-ACIDS | MYOCARDIAL-INFARCTION | DIETARY-SUPPLEMENTS | BLOOD-PRESSURE | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | REMNANT CHOLESTEROL | DOCOSAHEXAENOIC ACID | n-3 polyunsaturated fatty acids | FISH-OIL | EICOSAPENTAENOIC ACID | Fish oils | Health risk assessment | Mortality
Review | Cardiovascular outcomes | Heart failure | Myocardial infarction | Atherosclerosis | Cardiovascular disease | Inflammation | Endothelial function | Coronary heart disease | Arrhythmias | N-3 polyunsaturated fatty acids | CHRONIC HEART-FAILURE | LONG-CHAIN OMEGA-3-FATTY-ACIDS | MYOCARDIAL-INFARCTION | DIETARY-SUPPLEMENTS | BLOOD-PRESSURE | MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | REMNANT CHOLESTEROL | DOCOSAHEXAENOIC ACID | n-3 polyunsaturated fatty acids | FISH-OIL | EICOSAPENTAENOIC ACID | Fish oils | Health risk assessment | Mortality
Journal Article
Hospital Practice, ISSN 2154-8331, 02/2014, Volume 42, Issue 1, pp. 92 - 100
Despite remarkable decreases in the mortality of coronary heart disease, there is concern that continued high levels of cardiovascular risk in the population...
metabolic syndrome | cardiovascular prevention | coronary heart disease | diabetes mellitus | hypertension | lipoproteins | Cardiovascular Diseases - etiology | United States - epidemiology | Life Style | Primary Prevention | Comorbidity | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Healthy People Programs | Cardiovascular Diseases - epidemiology | Cause of Death
metabolic syndrome | cardiovascular prevention | coronary heart disease | diabetes mellitus | hypertension | lipoproteins | Cardiovascular Diseases - etiology | United States - epidemiology | Life Style | Primary Prevention | Comorbidity | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Healthy People Programs | Cardiovascular Diseases - epidemiology | Cause of Death
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 09/2019, Volume 41, Issue 9, pp. 1780 - 1797
Cardiovascular (CV) diseases account for most worldwide mortality, and a higher level of lipoprotein (Lp)-(a) is recognized as a prevalent contributing risk...
atherosclerosis | cardiovascular disease | lipoprotein | lipoprotein(a) | lipid profile | TRIMETHYLAMINE-N-OXIDE | LOW-DENSITY-LIPOPROTEIN | SUBTILISIN/KEXIN TYPE 9 | POSTPRANDIAL PLASMA-LIPIDS | L-CARNITINE | CASSETTE TRANSPORTER A1 | PHARMACOLOGY & PHARMACY | OXIDIZED PHOSPHOLIPIDS | CORONARY-HEART-DISEASE | CHRONIC KIDNEY-DISEASE | CARDIOVASCULAR RISK-FACTORS | Wine | Enzymes | Functional foods | Analysis | Mortality | Levocarnitine | Lipoprotein A | Isoflavones | Soybeans | Ascorbic acid | Clinical trials | Lipids | Cardiovascular disease | Coffee | Risk factors | Literature reviews | Exercise | Coenzyme Q10 | L-Carnitine | Supplementation | Food | Nutraceuticals | Functional foods & nutraceuticals | Antigens | Ethanol | Dietary supplements | Feasibility studies | Exploration | Risk analysis | Apolipoproteins | Patients | Carnitine | Tea | Physical fitness | Lipoproteins | Reviews | Diet | Searching | Garlic
atherosclerosis | cardiovascular disease | lipoprotein | lipoprotein(a) | lipid profile | TRIMETHYLAMINE-N-OXIDE | LOW-DENSITY-LIPOPROTEIN | SUBTILISIN/KEXIN TYPE 9 | POSTPRANDIAL PLASMA-LIPIDS | L-CARNITINE | CASSETTE TRANSPORTER A1 | PHARMACOLOGY & PHARMACY | OXIDIZED PHOSPHOLIPIDS | CORONARY-HEART-DISEASE | CHRONIC KIDNEY-DISEASE | CARDIOVASCULAR RISK-FACTORS | Wine | Enzymes | Functional foods | Analysis | Mortality | Levocarnitine | Lipoprotein A | Isoflavones | Soybeans | Ascorbic acid | Clinical trials | Lipids | Cardiovascular disease | Coffee | Risk factors | Literature reviews | Exercise | Coenzyme Q10 | L-Carnitine | Supplementation | Food | Nutraceuticals | Functional foods & nutraceuticals | Antigens | Ethanol | Dietary supplements | Feasibility studies | Exploration | Risk analysis | Apolipoproteins | Patients | Carnitine | Tea | Physical fitness | Lipoproteins | Reviews | Diet | Searching | Garlic
Journal Article
Human Reproduction, ISSN 0268-1161, 07/2016, Volume 31, Issue 7, pp. 1501 - 1507
Abstract Cryopreservation of oocytes has been proposed as a way of storing gametes in young patients at high risk of infertility and premature ovarian failure....
ANOVULATORY CYCLES | CRYOPRESERVED OVARIAN TISSUE | bone marrow transplant | HIGH-DOSE BUSULFAN | LIVE BIRTH | oocyte cryopreservation | CHILDHOOD-CANCER SURVIVOR | FAILURE | teenage girls | YOUNG GIRLS | FEMALE | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | ovarian stimulation | fertility preservation | QUALITY-OF-LIFE | Oocytes - growth & development | Age Factors | Cryopreservation | Ovulation Induction - methods | Humans | Adolescent | Bone Marrow Transplantation | Oocyte Retrieval - ethics | Female | Fertility Preservation - ethics | Oocyte Retrieval - methods
ANOVULATORY CYCLES | CRYOPRESERVED OVARIAN TISSUE | bone marrow transplant | HIGH-DOSE BUSULFAN | LIVE BIRTH | oocyte cryopreservation | CHILDHOOD-CANCER SURVIVOR | FAILURE | teenage girls | YOUNG GIRLS | FEMALE | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | ovarian stimulation | fertility preservation | QUALITY-OF-LIFE | Oocytes - growth & development | Age Factors | Cryopreservation | Ovulation Induction - methods | Humans | Adolescent | Bone Marrow Transplantation | Oocyte Retrieval - ethics | Female | Fertility Preservation - ethics | Oocyte Retrieval - methods
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 10/2019, Volume 292, pp. 39 - 40
Journal Article
Evidence-Based Medicine, ISSN 1356-5524, 06/2015, Volume 20, Issue 3, p. 111
Journal Article
Postgraduate Medicine, ISSN 0032-5481, 02/2018, Volume 130, Issue 2, pp. 200 - 221
The quest to optimize cardiometabolic health has created great interest in nonmedical health variables in the population, community-based research and...
risk factors | environment | health disparities | cardiometabolic outcomes | population health | type 2 diabetes | ethnicity | race | Cardiovascular risk | health equity | precision medicine | health promotion | LOW-INCOME PATIENTS | LIFE-STYLE INTERVENTION | RISK-FACTORS | PUBLIC-HEALTH | HIGH-INTENSITY STATIN | SOCIAL DETERMINANTS | AMERICAN-HEART-ASSOCIATION | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE | DIABETES PREVENTION PROGRAM | MEDICATION ADHERENCE
risk factors | environment | health disparities | cardiometabolic outcomes | population health | type 2 diabetes | ethnicity | race | Cardiovascular risk | health equity | precision medicine | health promotion | LOW-INCOME PATIENTS | LIFE-STYLE INTERVENTION | RISK-FACTORS | PUBLIC-HEALTH | HIGH-INTENSITY STATIN | SOCIAL DETERMINANTS | AMERICAN-HEART-ASSOCIATION | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE | DIABETES PREVENTION PROGRAM | MEDICATION ADHERENCE
Journal Article
Hospital Practice, ISSN 2154-8331, 08/2014, Volume 42, Issue 3, pp. 84 - 95
This article presents core epidemiological studies that establish the basis for cardiovascular prevention strategies. The results of the classic INTERHEART and...
American Heart Association metrics | cardiovascular risk and prevention | low-density lipoprotein cholesterol | coronary heart disease | hypertension | diabetes | obesity | Life Style | Myocardial Infarction - epidemiology | United States | Cardiovascular Diseases - prevention & control | Humans | Oxidative Stress - physiology | Secondary Prevention - methods | Exercise | Cardiovascular Diseases - epidemiology | Hypertension - prevention & control | Stroke - epidemiology | Hypertension - epidemiology | Stroke - prevention & control | Risk Factors | Coronary Artery Disease - prevention & control | Health Behavior | Diabetes Mellitus - prevention & control | Alcohol Drinking - epidemiology | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Obesity - prevention & control | Primary Prevention - methods | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Nitric Oxide - metabolism
American Heart Association metrics | cardiovascular risk and prevention | low-density lipoprotein cholesterol | coronary heart disease | hypertension | diabetes | obesity | Life Style | Myocardial Infarction - epidemiology | United States | Cardiovascular Diseases - prevention & control | Humans | Oxidative Stress - physiology | Secondary Prevention - methods | Exercise | Cardiovascular Diseases - epidemiology | Hypertension - prevention & control | Stroke - epidemiology | Hypertension - epidemiology | Stroke - prevention & control | Risk Factors | Coronary Artery Disease - prevention & control | Health Behavior | Diabetes Mellitus - prevention & control | Alcohol Drinking - epidemiology | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Obesity - prevention & control | Primary Prevention - methods | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Nitric Oxide - metabolism
Journal Article